文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

2022 年癌症发病估计数及 2025 年预测:印度国家癌症登记计划的结果。

Cancer incidence estimates for 2022 & projection for 2025: Result from National Cancer Registry Programme, India.

机构信息

National Centre for Disease Informatics & Research, Indian Council of Medical Research, Bengaluru, Karnataka, India.

出版信息

Indian J Med Res. 2022 Oct-Nov;156(4&5):598-607. doi: 10.4103/ijmr.ijmr_1821_22.


DOI:10.4103/ijmr.ijmr_1821_22
PMID:36510887
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10231735/
Abstract

BACKGROUND & OBJECTIVES: Information on recent cancer statistics is important for planning, monitoring and evaluating cancer control activities. This article aims to provide an update on the cancer incidence estimates in India by sex, age groups and anatomical sites for the year 2022. METHODS: The National Cancer Registry Programme Report 2020, reported the cancer incidence from 28 Population-Based Cancer Registries (PBCRs) for the years 2012-2016. This was used as the basis to calculate cancer estimates in India. Information pertaining to the population at risk was extracted from the Census of India (2001 and 2011) for the estimation of age-sex stratified population. PBCRs were categorised into the respective State and regions of the country to understand the epidemiology of cancer. The age-specific incidence rate for each specific anatomical site of cancer was applied to the estimated population to derive the number of cancer cases in India for 2022. RESULTS: The estimated number of incident cases of cancer in India for the year 2022 was found to be 14,61,427 (crude rate:100.4 per 100,000). In India, one in nine people are likely to develop cancer in his/her lifetime. Lung and breast cancers were the leading sites of cancer in males and females, respectively. Among the childhood (0-14 yr) cancers, lymphoid leukaemia (boys: 29.2% and girls: 24.2%) was the leading site. The incidence of cancer cases is estimated to increase by 12.8 per cent in 2025 as compared to 2020. INTERPRETATION & CONCLUSIONS: The cancer incidence is continuing to increase in India. The new estimates will be helpful in planning cancer prevention and control activities through the intervention of early detection, risk reduction and management.

摘要

背景与目的:了解癌症的最新统计数据对于规划、监测和评估癌症控制活动至关重要。本文旨在提供印度 2022 年按性别、年龄组和解剖部位划分的癌症发病率估计更新。

方法:国家癌症登记计划报告 2020 年报告了 28 个人口为基础的癌症登记处(PBCR)在 2012-2016 年期间的癌症发病率。这是计算印度癌症估计的基础。从印度人口普查(2001 年和 2011 年)中提取与风险人群相关的信息,用于估计年龄性别分层人口。根据该国的州和地区对 PBCR 进行分类,以了解癌症的流行病学。将每个特定解剖部位的癌症的年龄特异性发病率应用于估计的人口,以得出印度 2022 年的癌症病例数。

结果:印度 2022 年估计有 1461427 例新发病例(粗发病率:每 10 万人 100.4 例)。在印度,每九个人中就有一个人可能在一生中患上癌症。肺癌和乳腺癌分别是男性和女性中最常见的癌症部位。在儿童(0-14 岁)癌症中,淋巴白血病(男孩:29.2%,女孩:24.2%)是最常见的部位。与 2020 年相比,预计 2025 年癌症病例的发病率将增加 12.8%。

解释与结论:印度的癌症发病率仍在持续上升。新的估计将有助于通过早期发现、降低风险和管理等干预措施,规划癌症预防和控制活动。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4834/10231735/5822ca8b92e3/IJMR-156-598-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4834/10231735/d213b2a66d1f/IJMR-156-598-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4834/10231735/5822ca8b92e3/IJMR-156-598-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4834/10231735/d213b2a66d1f/IJMR-156-598-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4834/10231735/5822ca8b92e3/IJMR-156-598-g002.jpg

相似文献

[1]
Cancer incidence estimates for 2022 & projection for 2025: Result from National Cancer Registry Programme, India.

Indian J Med Res. 2022

[2]
Projection of cancer incident cases for India -till 2026.

Asian Pac J Cancer Prev. 2013

[3]
Italian cancer figures, report 2012: Cancer in children and adolescents.

Epidemiol Prev. 2013

[4]
Burden of cancers in India - estimates of cancer crude incidence, YLLs, YLDs and DALYs for 2021 and 2025 based on National Cancer Registry Program.

BMC Cancer. 2022-5-11

[5]
Projection of burden of cancer mortality for India, 2011-2026.

Asian Pac J Cancer Prev. 2013

[6]
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.

Epidemiol Prev. 2016

[7]
The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016.

Lancet Oncol. 2018-9-12

[8]
A clinicoepidemiological profile of lung cancers in India - Results from the National Cancer Registry Programme.

Indian J Med Res. 2022-2

[9]
Adolescent and young adult cancers in India-Findings from the National Cancer Registry Programme.

Cancer Epidemiol. 2022-6

[10]
Burden of cancer and projections for 2016, Indian scenario: gaps in the availability of radiotherapy treatment facilities.

Asian Pac J Cancer Prev. 2008

引用本文的文献

[1]
The SPINK Protein Family in Cancer: Emerging Roles in Tumor Progression, Therapeutic Resistance, and Precision Oncology.

Pharmaceuticals (Basel). 2025-8-13

[2]
Evolving Treatment Paradigms in Metastatic Hormone-Sensitive Prostate Cancer: Expert Narrative Review.

Curr Oncol. 2025-8-5

[3]
Epidemiology of Primary Intracranial Tumors at a Tertiary Care Hospital in Central India: A Retrospective Study.

Cureus. 2025-7-21

[4]
Cancer Incidence and Mortality Across 43 Cancer Registries in India.

JAMA Netw Open. 2025-8-1

[5]
Real-world data of CanAssist Breast- first immunohistochemistry and AI-based prognostic test.

Sci Rep. 2025-8-19

[6]
Behavioural risk factors of cancer among the general population in Manipur: Findings from the monitoring survey of cancer risk factors and health system response in North East Region.

J Family Med Prim Care. 2025-7

[7]
Assessing the acceptability, affordability, and availability of teleoncology services among cancer patients: A cross-sectional study.

J Family Med Prim Care. 2025-7

[8]
Knowledge, attitude, and practice among non-breast cancer women towards breast cancer screening with a focus on economic factors.

Sci Rep. 2025-8-14

[9]
The role of advanced diagnostics on precision medicine in hemato oncology.

Discov Oncol. 2025-8-11

[10]
Oncology Treatment in India: A Narrative Exploration of Patient Engagement and Care Strategies.

Cureus. 2025-7-5

本文引用的文献

[1]
A clinicoepidemiological profile of lung cancers in India - Results from the National Cancer Registry Programme.

Indian J Med Res. 2022-2

[2]
Burden of cancers in India - estimates of cancer crude incidence, YLLs, YLDs and DALYs for 2021 and 2025 based on National Cancer Registry Program.

BMC Cancer. 2022-5-11

[3]
Adolescent and young adult cancers in India-Findings from the National Cancer Registry Programme.

Cancer Epidemiol. 2022-6

[4]
Cancer statistics in China and United States, 2022: profiles, trends, and determinants.

Chin Med J (Engl). 2022-2-9

[5]
Cancer statistics, 2022.

CA Cancer J Clin. 2022-1

[6]
Trends in breast and cervical cancer in India under National Cancer Registry Programme: An Age-Period-Cohort analysis.

Cancer Epidemiol. 2021-10

[7]
Impact of COVID-19 on cancer care in India: a cohort study.

Lancet Oncol. 2021-7

[8]
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

CA Cancer J Clin. 2021-5

[9]
Cancer Statistics, 2020: Report From National Cancer Registry Programme, India.

JCO Glob Oncol. 2020-7

[10]
History of the Growing Burden of Cancer in India: From Antiquity to the 21st Century.

J Glob Oncol. 2019-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索